NUS
Nu Skin Enterprises Inc
4.60$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.7% | 46.9% | 48.5% | 48.9% | 47.2% | 41.8% | 46.2% | 45.8% | 41.7% | 38.9% | 36.7% | 39.0% | |
| 17.9% | 19.2% | 24.2% | 26.8% | 22.8% | 19.0% | 20.6% | 17.8% | 14.5% | 14.2% | 12.7% | 17.0% | |
| 18.6% | 20.2% | 25.0% | 27.6% | 23.5% | 19.4% | 21.7% | 18.6% | 15.3% | 14.8% | 13.5% | 17.1% | |
| 2.2% | 2.4% | 2.1% | 2.1% | 3.1% | 2.8% | 3.2% | 2.2% | 2.6% | 4.0% | 3.5% | 2.8% | |
| 21.0% | 17.6% | 17.0% | 15.9% | 17.5% | 15.6% | 16.1% | 21.0% | 19.0% | 15.5% | 13.0% | 12.7% | |
| 28.8% | 30.2% | 30.2% | 29.2% | 27.4% | 25.6% | 23.9% | 23.8% | 24.4% | 29.6% | 31.4% | 32.7% | |
| 7.0% | 7.5% | 7.8% | 7.2% | 11.6% | 11.1% | 10.4% | 10.8% | 11.3% | 12.8% | 5.7% | 6.0% | |
| 4.6% | 4.4% | 4.3% | 4.3% | 5.3% | 4.5% | 4.6% | 4.0% | 3.7% | 5.8% | 5.1% | 3.0% | |
| 41.6% | 45.2% | 54.9% | 55.7% | 53.9% | 50.5% | 54.3% | 52.1% | 50.7% | 54.5% | 55.7% | 42.7% | |
| 25.9% | 27.1% | 27.1% | 28.1% | 25.9% | 20.2% | 27.7% | 27.8% | 19.7% | 18.2% | 20.2% | 18.8% | |
| 5.1% | 4.5% | 5.6% | 4.9% | 4.1% | 3.8% | 3.8% | 7.4% | 3.0% | 2.7% | 3.3% | 2.7% | |
| 2.2% | 1.9% | 2.8% | 3.2% | 2.8% | 2.2% | 3.4% | 2.6% | 3.0% | 2.4% | 2.4% | 1.9% | |
| 10.2% | 12.1% | 22.7% | 19.5% | 21.3% | 18.9% | 15.6% | 14.1% | 20.7% | 26.5% | 24.8% | 14.5% | |
| 58.4% | 54.8% | 45.1% | 44.3% | 46.1% | 49.5% | 45.7% | 47.9% | 49.3% | 45.5% | 44.3% | 57.3% | |
| 89.3% | 99.2% | 105.7% | 101.2% | 96.5% | 97.7% | 94.1% | 100.3% | 106.5% | 103.5% | 116.5% | 132.4% | |
| 3.8% | 3.9% | 3.8% | 3.5% | 3.3% | 3.2% | 2.7% | 2.7% | 2.8% | 2.8% | 3.4% | 3.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.